# Version 1.0 General Availability Authorization

**Document ID:** `VPSYCH-1.0-GA-AUTH`  
**Version under review:** `1.0.0-rc.1`  
**Target GA version:** `1.0.0`  
**Date (UTC):** 2026-08-07  

| Field | Value |
|-------|-------|
| Reviewer | Phase 15 Release Board (collective) |
| Approval Status | **REJECTED — NO-GO** |
| Evidence Reference | `GET /api/admin/ops/phase15` · this folder |
| Digital Signature Placeholder | `[Board Chair attestation — not granted]` |

## Decision

# ❌ NO-GO — Do not authorize VPsych Version 1.0.0 General Availability

Remain on **Controlled Institutional Deployment** at `1.0.0-rc.1`.

## Board gate review

| Gate | Status at packaging |
|------|---------------------|
| Disaster Recovery completed | OPEN |
| PITR verified | OPEN |
| Security residuals closed | OPEN / PARTIAL |
| Infrastructure validated | PARTIAL |
| No unresolved Critical findings | PASS only if feedback+critical risks clear; seed critical-tier risks keep pressure |
| Pilot objectives achieved | OPEN (no registered pilots) |
| Clinical validation successful | PARTIAL / OPEN (scores unvalidated; pilot evidence empty) |
| Educational validation successful | OPEN |
| Research package complete | OPEN / PARTIAL |
| Governance approved | PASS (program docs) |
| Executive Board approval received | NOT YET / PENDING |

## Conditions to re-open motion

1. `evaluatePhase15Authorization().ga_status === "GO"`  
2. Signed DR + PITR rows in `../cidp/evidence/dr/DR_EVIDENCE_LOG.md`  
3. Security residuals closed or Board-waived (no Critical clinical waivers)  
4. Pilot completion `objectives_met=true` with longitudinal evidence  
5. Clinical / educational / research reports Board-accepted for the scoped claim set  
6. New RDL row authorizing `v1.0.0`  

## Explicit non-authorization actions

- Do **not** set `package.json` to `1.0.0`  
- Do **not** tag `v1.0.0`  
- Do **not** market unrestricted institutional GA  
- Do **not** claim validated competency instruments  
